Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
By Ernie Mundell HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- Beta blockers are go-to meds for many people who've survived a heart attack.
However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained a normal pumping ability.
Using them in this group might even raise patients' odds for depression, the data showed.
“We found that beta blockers led to slightly higher levels of depression symptoms in patients who had had a heart attack but were not suffering from heart failure," said study lead author Philip Leissner, a doctoral student in cardiac psychology at Uppsala University.
"At the same time, beta blockers have no life-sustaining function for this group of patients,” he said in a university news release.
His team published its findings recently in the European Heart Journal.
Heart doctors have for decades relied on beta blocker medications to help heart patients -- the drugs work by lowering the effects of adrenaline on the heart.
But recent advances mean there are now more pharmaceutical options for cardiologists to pick from for people who've survived a heart attack, putting the use of beta-blockers into question.
According to Leissner's team, that's especially true for folks who have survived a heart attack but whose cardiac pumping action has retained its efficacy. In a study published in April, the Swedish researchers found beta-blockers to be unnecessary for this type of patient.
Their newer study finds the drugs might even pose harm.
They looked at data from more than 800 heart attack survivors without heart failure who had either been prescribed a beta-blocker or some other form of medication after their heart attack. The study ran from 2018 to 2023.
"Beta blocker treatment led to a modest increase in depressive symptoms" for heart attack survivors who weren't in heart failure, the researchers reported.
That's not a complete surprise, they said, since prior studies have found beta blocker use tied to heightened odds for depression, insomnia and even nightmares.
The study also found that depression risks rose even higher among patients who'd already been taking a beta blocker before the study began, suggesting a dose-response relationship.
“Most doctors used to give beta blockers even to patients without heart failure, but as the evidence in favor of doing so is no longer so strong, this should be reconsidered," Leissner suggested. "We could see that some of these patients appear to be more at risk of depression. If the drug doesn’t make a difference to their heart, then they are taking it unnecessarily and at risk of becoming depressed."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-13 00:00
Read more
- 1 in 5 People Could Have Long COVID
- More Than One-Third Have ED Visit Within 90 Days Before Cancer Diagnosis
- JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
- Love Bread & Pasta? Humans' Hunger for Carbs Has Ancient Roots
- Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
- FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions